CertisOI Assistant™ is an easy-to-use tool that leverages OpenAI’s natural language model to provide unparalleled insights into oncology models and drug response. It empowers researchers to easily query both public and proprietary tumor model datasets, effortlessly refine queries and perform ad hoc analyses, and even download detailed data—all from one place, boosting efficiency and enabling faster decision-making in oncology research.
CertisOI Assistant generates charts and graphs to visualize data for greater insights. This is a scatter plot of PDX breast cancer models with negative expression of ERBB2 (HER2). The x-axis represents the model names, the y-axis represents the log2 fold change, and the color intensity represents the transcripts per million. Models with lower log2 fold change values have more negative expression.
Focused uniquely on cancer research, this one-of-a-kind chatbot is integrated with CertisAI™, a validated, patent-pending AI/ML platform that predicts therapeutic efficacy by identifying complex gene expression biomarkers that correlate with drug response.
This integration gives users no-charge access to many powerful features of CertisAI™, including efficacy predictions for FDA-approved drugs used in combination.